iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Down 90.9% in December

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 4,806 shares, a drop of 90.9% from the November 30th total of 52,638 shares. Based on an average trading volume of 3,507 shares, the short-interest ratio is currently 1.4 days. Approximately 2.4% of the company’s shares are sold short. Approximately 2.4% of the company’s shares are sold short. Based on an average trading volume of 3,507 shares, the short-interest ratio is currently 1.4 days.

iShares Health Innovation Active ETF Stock Performance

iShares Health Innovation Active ETF stock traded down $0.13 during trading on Friday, reaching $30.71. The company had a trading volume of 1,127 shares, compared to its average volume of 2,203. iShares Health Innovation Active ETF has a 12-month low of $20.57 and a 12-month high of $30.95. The stock’s 50 day moving average price is $29.59 and its two-hundred day moving average price is $27.09. The firm has a market capitalization of $6.14 million, a price-to-earnings ratio of 24.91 and a beta of 0.84.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.